
HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial
Keywords: منطقه تعریف حساسیت اینترفرون; BL; baseline; BLQ; below limit of quantification; BN; Bayesian network; (c)DNA; (copy) deoxyribonucleic acid; CsA; cyclosporine A; DAA; direct-acting antiviral; dN; non-synonymous nucleotide change; dS; synonymous nucleotide change; EC50; half maximal eff